Canaccord Genuity Maintains Buy on GH Research, Raises Price Target to $31

Benzinga · 05/06 17:32
Canaccord Genuity analyst Sumant Kulkarni maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $30 to $31.